Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
164.83
+4.00 (2.49%)
Dec 20, 2024, 4:00 PM EST - Market closed

Krystal Biotech Revenue

Krystal Biotech had revenue of $83.84M in the quarter ending September 30, 2024, with 879.91% growth. This brings the company's revenue in the last twelve months to $241.52M, up 2,722.80% year-over-year. In the year 2023, Krystal Biotech had annual revenue of $50.70M.

Revenue (ttm)
$241.52M
Revenue Growth
+2,722.80%
P/S Ratio
19.41
Revenue / Employee
$1,054,668
Employees
229
Market Cap
4.74B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202350.70M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Integer Holdings 1.71B
Alkermes 1.51B
Apellis Pharmaceuticals 715.22M
Telix Pharmaceuticals 430.80M
Axsome Therapeutics 338.46M
TG Therapeutics 264.79M
BridgeBio Pharma 217.77M
PROCEPT BioRobotics 199.84M
Revenue Rankings